Read all the latest updates on our charity, clinical advances in melanoma treatment, patient stories, fundraising and events.
Melanoma Focus are delighted with the news that the SMC have approved the recommendation of pembrolizumab as an option for the adjuvant treatment of completely resected stage 2B or 2C melanoma in people 12 years and over in Scotland.
Clinical Advances
Read more
To improve treatment for all melanoma patients, the United Kingdom is building the world’s biggest source of data, which researchers can use in global research studies aiming to further advance melanoma care.
Clinical Advances
Read more
The OPTIC study has just opened to recruitment, and researchers want to interview patients in groups to find out their opinion about how immunotherapy treatment is given.
Clinical Advances
Read more
This study is now closed. Cerner Enviza, an independent research agency, is collaborating with a sponsoring pharmaceutical company, with the assistance of Melanoma Focus and Global Patients, to conduct an online research to collect the opinion of patients with stage 2, 3 or 4 melanoma about the potential benefits and risks related to melanoma treatments.
Clinical Advances
Read more
Melanoma Focus are delighted with the news that NICE have approved the recommendation of pembrolizumab as an option for the adjuvant treatment of completely resected stage 2B or 2C melanoma in people 12 years and over.
Clinical Advances
Read more
NICE have published the updated melanoma: assessment and management guidelines.
Clinical Advances
Read more
Melanoma Focus are pleased to hear that the MHRA have licensed Tebentafusp for use in the UK
Clinical Advances
Read more
Melanoma Focus are pleased to announce that an update to our uveal melanoma guidelines has now been published.
Clinical Advances
Read more
February 2021: NICE Recommends MSD’s KEYTRUDA® (pembrolizumab) for Routine Commissioning as Monotherapy for the Adjuvant Treatment of Adults with Stage III Melanoma with Lymph Node Involvement Who Have Undergone Complete Resection
Clinical Advances
Read more
A group of clinicians, nurses and patient & carer representatives began work in mid-2018 to produce a national clinical guideline for head & neck mucosal melanoma.
Clinical Advances
Read more
Skin cancer is one of the most common cancers in the world, and the incidence is increasing. Could skin cancer detection be transformed by innovative technologies such as digital medicine and artificial intelligence?
Clinical Advances
Read more
The sentinel node biopsy (SNB) surgical procedure has been used in the staging of melanoma patients for the many years.
Clinical Advances
Read more
